NEOSCOPE: a randomised Phase II study of induction chemotherapy followed by either oxaliplatin/capecitabine or paclitaxel/carboplatin based chemoradiation as pre-operative regimen for resectable oesophageal adenocarcinoma.

NEOSCOPE: a randomised Phase II study of induction chemotherapy followed by either oxaliplatin/capecitabine or paclitaxel/carboplatin based chemoradiation as pre-operative regimen for resectable oesophageal adenocarcinoma.

Εμφάνιση άλλων εκδόσεων (1)

BACKGROUND: Both oxaliplatin/capecitabine-based chemoradiation (OXCAP-RT) and carboplatin-paclitaxel based radiation (CarPac-RT) are active regimens in oesophageal adenocarcinoma, but no randomised study has compared their efficacy and toxicity. This randomised phase II "pick a winner" tri...

Πλήρης περιγραφή

Λεπτομέρειες βιβλιογραφικής εγγραφής
Κύριοι συγγραφείς:	Mukherjee, S, Hurt, C, Gwynne, S, Bateman, A, Gollins, S, Radhakrishna, G, Hawkins, M, Canham, J, Lewis, W, Grabsch, H, Sharma, R, Wade, W, Maggs, R, Tranter, B, Roberts, A, Sebag-Montefiore, D, Maughan, T, Griffiths, G, Crosby, T
Μορφή:	Journal article
Γλώσσα:	English
Έκδοση:	2015

Παρόμοια τεκμήρια

NEOSCOPE: a randomised Phase II study of induction chemotherapy followed by either oxaliplatin/capecitabine or paclitaxel/carboplatin based chemoradiation as pre-operative regimen for resectable oesophageal adenocarcinoma.
ανά: Mukherjee, S, κ.ά.
Έκδοση: (2015)

NEOSCOPE: A randomised phase II study of induction chemotherapy followed by oxaliplatin/capecitabine or carboplatin/paclitaxel based pre-operative chemoradiation for resectable oesophageal adenocarcinoma
ανά: Mukherjee, S, κ.ά.
Έκδοση: (2017)

NeoSCOPE RTTQA: pre-accrual and on-trial review of all patients in a UK oesophageal RT trial
ανά: Evans, E, κ.ά.
Έκδοση: (2018)

Preliminary phase IISOCRATES study results: Capecitabine (CAP) combined with oxaliplatin (OX) and preoperative radiation (IRT) in patients (pts) with locally advanced rectal cancer (LARC).
ανά: Glynne-Jones, R, κ.ά.
Έκδοση: (2004)

Socrates phase II study results: Capecitabine (CAP) combined with oxaliplatin (OX) and preoperative radiation (RT) in patients (pts) with locally advanced rectal cancer (LARC).
ανά: Glynne-Jones, R, κ.ά.
Έκδοση: (2005)

P-233: SCALOP-2: A multi-centre randomised study of induction chemotherapy followed by capecitabine (+/- nelfinavir) with high or standard dose radiotherapy for locally advanced non-metastatic pancreatic cancer
ανά: Virdee, P, κ.ά.
Έκδοση: (2017)

Oxaliplatin/capecitabine vs oxaliplatin/infusional 5-FU in advanced colorectal cancer: the MRC COIN trial.
ανά: Madi, A, κ.ά.
Έκδοση: (2012)

Oxaliplatin/capecitabine vs oxaliplatin/infusional 5-FU in advanced colorectal cancer: The MRC COIN trial
ανά: Madi, A, κ.ά.
Έκδοση: (2012)

Long-term results and recurrence patterns from SCALOP: a phase II randomised trial of gemcitabine- or capecitabine-based chemoradiation for locally advanced pancreatic cancer
ανά: Hurt, C, κ.ά.
Έκδοση: (2017)

Oesophageal Chemoradiotherapy in the UK-Current Practice and Future Directions
ανά: Gwynne, S, κ.ά.
Έκδοση: (2013)

Oesophageal Chemoradiotherapy in the UK--current practice and future directions.
ανά: Gwynne, S, κ.ά.
Έκδοση: (2013)

Study protocol: a multi-centre randomised study of induction chemotherapy followed by capecitabine ± nelfinavir with high- or standard-dose radiotherapy for locally advanced pancreatic cancer (SCALOP-2)
ανά: Strauss, V, κ.ά.
Έκδοση: (2019)

Concurrent chemoradiation of metastases with capecitabine and oxaliplatin and 3D-CRT in patients with oligometastatic colorectal cancer: results of a phase I study
ανά: Dellas Kathrin, κ.ά.
Έκδοση: (2012-06-01)

SCALOP-2: A multi-centre randomised study of induction chemotherapy followed by capecitabine (+/- nelfinavir) with high or standard dose radiotherapy for locally advanced non-metastatic pancreatic cancer
ανά: Virdee, P, κ.ά.
Έκδοση: (2017)

Economic comparison of capecitabine + oxaliplatin and 5-fluorouracil + oxaliplatin in the adjuvant treatment of colon cancer
ανά: Colombo GL., κ.ά.
Έκδοση: (2012-03-01)

Efficacy of early PET-CT directed switch to carboplatin and paclitaxel based definitive chemoradiotherapy in patients with oesophageal cancer who have a poor early response to induction cisplatin and capecitabine in the UK: a multi-centre randomised controlled phase II trialResearch in context
ανά: Somnath Mukherjee, κ.ά.
Έκδοση: (2023-07-01)

Study protocol: a multi-centre randomised study of induction chemotherapy followed by capecitabine ± nelfinavir with high- or standard-dose radiotherapy for locally advanced pancreatic cancer (SCALOP-2)
ανά: Victoria Y. Strauss, κ.ά.
Έκδοση: (2019-02-01)

A phase I/II study of oxaliplatin when added to 5-fluorouracil and leucovorin and pelvic radiation in locally advanced rectal cancer: a Colorectal Clinical Oncology Group (CCOG) study.
ανά: Sebag-Montefiore, D, κ.ά.
Έκδοση: (2005)

Cost-effectiveness analysis of capecitabine monotherapy versus capecitabine plus oxaliplatin in elderly patients with advanced gastric cancer.
ανά: Jingyuan Peng, κ.ά.
Έκδοση: (2018-01-01)

SCALOP-2: A randomised trial of induction GEMABX followed by chemoradiation (high/standard dose radiation) +/-nelfinavir for locally advanced pancreatic cancer: results of the dose-finding component
ανά: Mukherjee, S, κ.ά.
Έκδοση: (2018)

A pilot study of the use of Oxaliplatin in metastatic colorectal cancer at Velindre
ανά: Mitra, S, κ.ά.
Έκδοση: (2001)

Analysis of capecitabine plus oxaliplatin (xelox) combination in the management of metastatic colorectal cancer compare with fluorouracil and oxaliplatin combination (folfox)
ανά: Isnatin Miladiyah
Έκδοση: (2016-12-01)

Neoadjuvant Capecitabine and Oxaliplatin Before Concurrent Capecitabine and Radiation in Locally Advanced Rectal Cancers: Experience of a Cancer Hospital in Pakistan
ανά: Muhammad Atif Mansha, κ.ά.
Έκδοση: (2021-12-01)

Acute mania due to capecitabine and oxaliplatin in a patient with metastatic colorectal cancer
ανά: Parikshit Padhi
Έκδοση: (2023-03-01)

First reported case of ANCA-associated vasculitis induced by oxaliplatin, capecitabine, and trastuzumab
ανά: Bengang Huo, κ.ά.
Έκδοση: (2023-12-01)

SCALOP-2: A multi-centre randomised trial of induction chemotherapy followed by capecitabine +/-nelfinavir with high or standard dose radiotherapy for locally advanced pancreatic cancer (LAPC): Results of stage 1 - the non-randomised dose-finding component
ανά: Mukherjee, S, κ.ά.
Έκδοση: (2018)

Definitive chemoradiation in patients with inoperable oesophageal carcinoma.
ανά: Crosby, T, κ.ά.
Έκδοση: (2004)

Preoperative chemoradiotherapy with capecitabine and triweekly oxaliplatin versus capecitabine monotherapy for locally advanced rectal cancer: a propensity-score matched study
ανά: Anchuan Li, κ.ά.
Έκδοση: (2022-07-01)

Relapsed urachal carcinoma responding to first‐line chemotherapy with capecitabine‐oxaliplatin plus bevacizumab
ανά: Akihiko Hatano, κ.ά.
Έκδοση: (2023-11-01)

Real-world efficacy and safety of capecitabine with oxaliplatin in patients with advanced adenocarcinoma of the ampulla of Vater
ανά: Seunghwan Lee, κ.ά.
Έκδοση: (2024-05-01)

Cost-Effectiveness Analysis of Capecitabine Plus Oxaliplatin Versus Gemcitabine Plus Oxaliplatin as First-Line Therapy for Advanced Biliary Tract Cancers
ανά: Ruijia Chen, κ.ά.
Έκδοση: (2022-07-01)

Multidisciplinary approach to the management of capecitabine-associated hand foot syndrome in cancer patients receiving capecitabine plus oxaliplatin and bevacizumab for advanced colorectal cancer
ανά: Hiroshi Matsuoka, κ.ά.
Έκδοση: (2017-02-01)

Capecitabine (X) and oxaliplatin (O) combination chemotherapy in patients (pts) with advanced gall bladder or biliary tract cancer: A phase II study
ανά: Evans, T, κ.ά.
Έκδοση: (2006)

Gemcitabine-based or capecitabine-based chemoradiotherapy for locally advanced pancreatic cancer (SCALOP): a multicentre, randomised, phase 2 trial.
ανά: Mukherjee, S, κ.ά.
Έκδοση: (2013)

Mitomycin or cisplatin chemoradiation with or without maintenance chemotherapy for treatment of squamous-cell carcinoma of the anus (ACT II): a randomised, phase 3, open-label, 2 × 2 factorial trial.
ανά: James, R, κ.ά.
Έκδοση: (2013)

Potential of Proton Therapy to Reduce Acute Hematologic Toxicity in Concurrent Chemoradiation Therapy for Esophageal Cancer
ανά: Warren, S, κ.ά.
Έκδοση: (2017)

Interdisciplinary Healthcare Team Experience of Carboplatin and Oxaliplatin Desensitizations in a Tertiary Referral University Hospital
ανά: Tunakan Dalgic C, κ.ά.
Έκδοση: (2023-07-01)

Comparison of neoadjuvant chemoradiation with carboplatin/ paclitaxel or cisplatin/ 5-fluoruracil in patients with squamous cell carcinoma of the esophagus
ανά: Stefan Münch, κ.ά.
Έκδοση: (2017-11-01)

SCOPE1: a randomised phase II/III multicentre clinical trial of definitive chemoradiation, with or without cetuximab, in carcinoma of the oesophagus
ανά: Staffurth John N, κ.ά.
Έκδοση: (2011-10-01)

Radiobiological determination of dose escalation and normal tissue toxicity in definitive chemoradiation therapy for esophageal cancer.
ανά: Warren, S, κ.ά.
Έκδοση: (2014)